title: Specialist initiation and monitoring of β blockers in patients with chronic heart failure and concomitant obstructive airways disease.
authors.forename: W R
authors.initials: WR
authors.lastname: Critchley
authors.forename: B
authors.initials: B
authors.lastname: Al-Sheklly
authors.forename: B
authors.initials: B
authors.lastname: Sekar
authors.forename: T
authors.initials: T
authors.lastname: Coppinger
authors.forename: C
authors.initials: C
authors.lastname: Waywell
authors.forename: C T
authors.initials: CT
authors.lastname: Leonard
authors.forename: R
authors.initials: R
authors.lastname: Niven
authors.forename: S G
authors.initials: SG
authors.lastname: Williams
authors.forename: S M
authors.initials: SM
authors.lastname: Shaw
mesh_terms: D000319:Adrenergic beta-Antagonists / Q000097:blood / Q000627:therapeutic use*; D000368:Aged; D000369:Aged, 80 and over; D015331:Cohort Studies; D016903:Drug Monitoring / Q000379:methods* / Q000592:standards; D005260:Female; D006333:Heart Failure / Q000097:blood / Q000175:diagnosis / Q000188:drug therapy*; D006801:Humans; D008173:Lung Diseases, Obstructive / Q000097:blood / Q000175:diagnosis / Q000188:drug therapy*; D008297:Male; D008875:Middle Aged; D013038:Specialization / Q000592:standards
chemical_list: D000319:Adrenergic beta-Antagonists